Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metis Biomedical is a San Diego-based biotechnology company specializing in the development of next-generation mRNA therapeutics and vaccines. The company utilizes its proprietary Topo-m (Topological mRNA) platform to engineer mRNA molecules with enhanced stability, durability, and translation efficiency compared to conventional linear mRNA. By optimizing the structural topology of mRNA, Metis aims to overcome current limitations in drug delivery and protein expression. Their research focus spans across infectious diseases, oncology, and rare genetic disorders. The company is led by experienced industry veterans with expertise in drug delivery and nucleic acid chemistry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metis Biomedical.